Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 May 1;69(1):98-108.
doi: 10.1097/QAI.0000000000000553.

Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013

Affiliations
Meta-Analysis

Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013

Matthew P Fox et al. J Acquir Immune Defic Syndr. .

Abstract

Background: We previously published systematic reviews of retention in care after antiretroviral therapy initiation among general adult populations in sub-Saharan Africa. We estimated 36-month retention at 73% for publications from 2007 to 2010. This report extends the review to cover 2008-2013 and expands it to all low- and middle-income countries.

Methods: We searched PubMed, Embase, Cochrane Register, and ISI Web of Science from January 1, 2008, to December 31, 2013, and abstracts from AIDS and IAS from 2008-2013. We estimated retention across cohorts using simple averages and interpolated missing times through the last time reported. We estimated all-cause attrition (death, loss to follow-up) for patients receiving first-line antiretroviral therapy in routine settings in low- and middle-income countries.

Results: We found 123 articles and abstracts reporting retention for 154 patient cohorts and 1,554,773 patients in 42 countries. Overall, 43% of all patients not retained were known to have died. Unweighted averages of reported retention were 78%, 71%, and 69% at 12, 24, and 36 months, after treatment initiation, respectively. We estimated 36-month retention at 65% in Africa, 80% in Asia, and 64% in Latin America and the Caribbean. From lifetable analysis, we estimated retention at 12, 24, 36, 48, and 60 months at 83%, 74%, 68%, 64%, and 60%, respectively.

Conclusions: Retention at 36 months on treatment averages 65%-70%. There are several important gaps in the evidence base, which could be filled by further research, especially in terms of geographic coverage and duration of follow-up.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest and sources of funding: We declare no conflicts of interest.

Figures

Figure 1
Figure 1
Average retention at specified time points, by region* * Note: Y axis starts at 40%
Figure 2
Figure 2
– Forest plots of retention by time period reported to at 12, 24, 36 and 48 months on ART* * Figure of 48 month retention includes 48 month retention (sometimes interpolated) for all cohorts reporting beyond 48 months
Figure 2
Figure 2
– Forest plots of retention by time period reported to at 12, 24, 36 and 48 months on ART* * Figure of 48 month retention includes 48 month retention (sometimes interpolated) for all cohorts reporting beyond 48 months
Figure 3
Figure 3
a–d Kaplan-Meir curves of time to attrition for all adults and stratified by region* * Kaplan Meir data use interpolated estimates

Comment in

References

    1. World Health Organization. HIV/AIDS Fact Sheet N360. 2014 Available from: http://www.who.int/mediacentre/factsheets/fs360/en//. Accessed 11 December, 2014.
    1. World Health Organization. Global update on HIV treatment 2013: results, impact and opportunities. 2013 Available: http://www.who.int/hiv/pub/progressreports/update2013/en/. Accessed 19 May, 2014.
    1. Bor J, Herbst AJ, Newell M-L, Bärnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013;339:961–965. doi: 10.1126/science.1230413. - DOI - PMC - PubMed
    1. Lessells RJ, Mutevedzi PC, Iwuji CC, Newell M-L. Reduction in early mortality on antiretroviral therapy for adults in rural South Africa since change in CD4+ cell count eligibility criteria. J Acquir Immune Defic Syndr E-pub ahea. 2013 doi: 10.1097/QAI.0b013e31829ceb14. - DOI - PMC - PubMed
    1. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4:e298. doi: 10.1371/journal.pmed.0040298. - DOI - PMC - PubMed

Publication types

Substances